MS4A12

gene
On this page

Also known as Ms4a10FLJ20217

Summary

MS4A12 (membrane spanning 4-domains A12, HGNC:13370) is a protein-coding gene on chromosome 11q12.2, encoding Membrane-spanning 4-domains subfamily A member 12 (Q9NXJ0). May be involved in signal transduction as a component of a multimeric receptor complex.

The protein encoded by this gene is a cell surface protein found primarily in the apical membrane of colonocytes. Silencing of this gene in colon cancer cells inhibits the proliferation, cell motility, and chemotactic invasion of cells. This gene is part of a cluster of similar genes found on chromosome 11. Two transcript variants encoding different isoforms have been found for this gene.

Source: NCBI Gene 54860 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 89 total
  • MANE Select transcript: NM_017716

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13370
Approved symbolMS4A12
Namemembrane spanning 4-domains A12
Location11q12.2
Locus typegene with protein product
StatusApproved
AliasesMs4a10, FLJ20217
Ensembl geneENSG00000071203
Ensembl biotypeprotein_coding
OMIM606550
Entrez54860

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 9 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000016913, ENST00000525951, ENST00000526784, ENST00000530007, ENST00000537076, ENST00000880034, ENST00000880035, ENST00000971815, ENST00000971816, ENST00000971817

RefSeq mRNA: 2 — MANE Select: NM_017716 NM_001164470, NM_017716

CCDS: CCDS53638, CCDS7988

Canonical transcript exons

ENST00000016913 — 7 exons

ExonStartEnd
ENSE000007200026050104560501182
ENSE000007200066050198360502039
ENSE000007200126050370160503817
ENSE000007200206050672860506838
ENSE000011079226050702060507430
ENSE000011079236049731360497594
ENSE000011079246049277860492828

Expression profiles

Bgee: expression breadth broad, 70 present calls, max score 99.18.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0588 / max 40.4611, expressed in 5 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1144780.05885

Top tissues by expression

247 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
mucosa of transverse colonUBERON:000499199.18gold quality
rectumUBERON:000105299.14gold quality
colonic mucosaUBERON:000031798.86gold quality
mucosa of sigmoid colonUBERON:000499398.53gold quality
transverse colonUBERON:000115789.30gold quality
ileal mucosaUBERON:000033186.59gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099186.57gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047385.03gold quality
vermiform appendixUBERON:000115477.86gold quality
large intestineUBERON:000005976.43gold quality
colonUBERON:000115575.54gold quality
caecumUBERON:000115372.14gold quality
colonic epitheliumUBERON:000039771.49gold quality
intestineUBERON:000016066.34gold quality
diaphragmUBERON:000110363.06gold quality
tibialis anteriorUBERON:000138558.31silver quality
smooth muscle tissueUBERON:000113558.22gold quality
quadriceps femorisUBERON:000137755.99gold quality
vastus lateralisUBERON:000137955.86gold quality
Brodmann (1909) area 46UBERON:000648355.74gold quality
nasal cavity epitheliumUBERON:000538452.22gold quality
muscle layer of sigmoid colonUBERON:003580552.02gold quality
left ventricle myocardiumUBERON:000656651.22gold quality
deltoidUBERON:000147651.04gold quality
right coronary arteryUBERON:000162550.59gold quality
thymusUBERON:000237049.70gold quality
myocardiumUBERON:000234949.68gold quality
pancreatic ductal cellCL:000207949.55silver quality
epithelial cell of pancreasCL:000008349.39gold quality
blood vessel layerUBERON:000479749.29gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-125970yes1264.28
E-ANND-3yes14.59

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): CDX2

miRNA regulators (miRDB)

25 targeting MS4A12, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-607799.9968.042299
HSA-MIR-548N99.9871.944170
HSA-MIR-651-3P99.9473.485177
HSA-MIR-4778-3P99.9370.401818
HSA-MIR-450B-5P99.9271.483175
HSA-MIR-576-5P99.8470.462582
HSA-MIR-451799.7669.191867
HSA-MIR-4524A-3P99.7266.852406
HSA-MIR-7161-5P99.6868.921592
HSA-MIR-548U99.6567.781463
HSA-MIR-432899.5771.064094
HSA-MIR-216A-5P99.5068.021288
HSA-MIR-446099.3768.52615
HSA-MIR-124499.3368.38832
HSA-MIR-4477B99.2370.491733
HSA-MIR-371A-5P99.0866.511914
HSA-MIR-4477A98.8369.752952
HSA-MIR-5006-5P98.7966.921246
HSA-MIR-6864-5P98.3866.591079
HSA-MIR-7852-3P98.3767.98823
HSA-MIR-338-3P98.1467.381137
HSA-MIR-120297.1966.43827
HSA-MIR-397297.1966.46808
HSA-MIR-151A-3P95.5265.29516
HSA-MIR-4670-5P77.2263.4120

Literature-anchored findings (GeneRIF, showing 4)

  • MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes. (PMID:18451174)
  • RNA interference of CDX1 and CDX2 and chromatin immunoprecipitation in colon cancer cells revealed that MS4A12 transcript and protein expression is essentially dependent on the presence of endogenous CDX2. (PMID:19781065)
  • In early stage colon cancer, the patients with low MS4A12 expression had a poor survival, while in advanced stage colon cancer MS412 had little prognostic value. (PMID:27881006)
  • CLCA4 and MS4A12 as the significant gene biomarkers of primary colorectal cancer. (PMID:32797167)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusMs4a12ENSMUSG00000101031
rattus_norvegicusMs4a12ENSRNOG00000026387

Paralogs (16): MS4A6A (ENSG00000110077), MS4A4A (ENSG00000110079), MS4A3 (ENSG00000149516), MS4A2 (ENSG00000149534), MS4A1 (ENSG00000156738), MS4A6E (ENSG00000166926), MS4A7 (ENSG00000166927), MS4A14 (ENSG00000166928), MS4A5 (ENSG00000166930), MS4A8 (ENSG00000166959), MS4A15 (ENSG00000166961), MS4A10 (ENSG00000172689), TMEM212 (ENSG00000186329), MS4A13 (ENSG00000204979), MS4A18 (ENSG00000214782), MS4A4E (ENSG00000214787)

Protein

Protein identifiers

Membrane-spanning 4-domains subfamily A member 12Q9NXJ0 (reviewed: Q9NXJ0)

All UniProt accessions (3): Q9NXJ0, E9PIX5, E9PNI3

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in signal transduction as a component of a multimeric receptor complex.

Subcellular location. Membrane.

Similarity. Belongs to the MS4A family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9NXJ0-11yes
Q9NXJ0-22

RefSeq proteins (2): NP_001157942, NP_060186* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR007237CD20-like_TMDomain
IPR030417MS4AFamily

Pfam: PF04103

UniProt features (16 total): topological domain 5, transmembrane region 4, sequence conflict 3, chain 1, region of interest 1, splice variant 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9NXJ0-F171.300.38

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 48 (showing top): SABATES_COLORECTAL_ADENOMA_DN, MARTENS_TRETINOIN_RESPONSE_UP, BRUINS_UVC_RESPONSE_LATE, FEVR_CTNNB1_TARGETS_UP, PRC2_EZH2_UP.V1_DN, MIR616_5P, MIR371B_5P, MIR373_5P, MIR651_3P, MIR450B_5P, MIR4477A, MIR4516, MIR4477B, MIR6780A_5P, MIR4517

GO Biological Process (1): cell surface receptor signaling pathway (GO:0007166)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
signal transduction1
binding1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

508 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
MS4A12MS4A6EQ96DS6927
MS4A12MS4A4EQ96PG1915
MS4A12ZG16O60844744
MS4A12GUCA2AQ02747652
MS4A12CLCA4Q14CN2624
MS4A12GUCA2BQ16661621
MS4A12TMIGD1Q6UXZ0601
MS4A12KRT20P35900563
MS4A12AQP8O94778544
MS4A12OOSP4BA0A2R8Y4Y8507
MS4A12REG4Q9BYZ8498
MS4A12SLC26A3P40879488
MS4A12TMEM176AQ96HP8487
MS4A12MS4A5Q9H3V2478
MS4A12TFF3Q07654460

IntAct

17 interactions, top by confidence:

ABTypeScore
MS4A12MALLpsi-mi:“MI:0915”(physical association)0.720
PLLPMS4A12psi-mi:“MI:0915”(physical association)0.720
MS4A12PLLPpsi-mi:“MI:0915”(physical association)0.720
MALLMS4A12psi-mi:“MI:0915”(physical association)0.720
MS4A12FAM3Apsi-mi:“MI:0915”(physical association)0.560
FAM3AMS4A12psi-mi:“MI:0915”(physical association)0.560
MS4A12STOMpsi-mi:“MI:0914”(association)0.350
MALLMS4A12psi-mi:“MI:0915”(physical association)0.000
PLLPMS4A12psi-mi:“MI:0915”(physical association)0.000

BioGRID (10): MS4A12 (Two-hybrid), MS4A12 (Two-hybrid), FAM3A (Two-hybrid), PLLP (Two-hybrid), MALL (Two-hybrid), MYADM (Affinity Capture-MS), ATP6V0A1 (Affinity Capture-MS), ATP6V0A2 (Affinity Capture-MS), STOM (Affinity Capture-MS), TMEM63B (Affinity Capture-MS)

ESM2 similar proteins: A0A0A7EPL0, A2RV66, A4QP16, A6QPF4, C4QM85, F4JYG0, O35892, P11836, P13386, P19437, P20490, P41739, P53762, P56645, P70326, P79778, Q01362, Q148B6, Q29131, Q3C1V0, Q3C2E2, Q3SA47, Q3UNB8, Q3V3Q4, Q3YBM2, Q5I2P1, Q5JT82, Q5R8D6, Q5R8E0, Q60HE7, Q68FU0, Q6A058, Q8BVM2, Q8N1N2, Q8NDZ0, Q8QGQ8, Q8WUU8, Q920C4, Q92540, Q96HJ5

Diamond homologs: A6QPF4, P11836, P13386, P19437, P20490, Q01362, Q3C1V0, Q3C2E2, Q3UPL6, Q8N5U1, Q920C4, Q96JA4, Q96JQ5, Q99N05, Q99N07, Q99N09, Q99N10, Q9BY19, Q9H2W1, Q9H3V2, Q9NXJ0, Q96HJ5, Q99N08, Q5REZ6, Q96PG2, Q9GZW8, Q99N03, Q96PG1, Q96DS6, Q2YDM3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

89 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance80
Likely benign6
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

823 predictions. Top by Δscore:

VariantEffectΔscore
11:60503697:T:Gacceptor_gain1.0000
11:60503697:TTAG:Tacceptor_loss1.0000
11:60503700:G:GTacceptor_loss1.0000
11:60503813:CCGTG:Cdonor_gain1.0000
11:60503815:GTG:Gdonor_gain1.0000
11:60503816:TG:Tdonor_gain1.0000
11:60503817:GG:Gdonor_gain1.0000
11:60503818:G:GGdonor_gain1.0000
11:60503819:TAA:Tdonor_loss1.0000
11:60506719:T:TAacceptor_gain1.0000
11:60506726:A:AGacceptor_gain1.0000
11:60506727:G:GGacceptor_gain1.0000
11:60492829:G:GGdonor_gain0.9900
11:60501085:G:GTdonor_gain0.9900
11:60501120:G:GTdonor_gain0.9900
11:60503686:T:Aacceptor_gain0.9900
11:60503690:A:AGacceptor_gain0.9900
11:60503691:T:Gacceptor_gain0.9900
11:60503696:A:AGacceptor_gain0.9900
11:60503699:A:AGacceptor_gain0.9900
11:60503700:G:GGacceptor_gain0.9900
11:60503700:GGT:Gacceptor_gain0.9900
11:60503814:CGTG:Cdonor_gain0.9900
11:60503815:GTGG:Gdonor_gain0.9900
11:60503816:TGGT:Tdonor_gain0.9900
11:60503817:GGTA:Gdonor_gain0.9900
11:60506718:AT:Aacceptor_gain0.9900
11:60506719:T:Gacceptor_gain0.9900
11:60506724:TCA:Tacceptor_loss0.9900
11:60506725:CA:Cacceptor_loss0.9900

AlphaMissense

1744 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
11:60503731:A:CS168R0.987
11:60503733:T:AS168R0.987
11:60503733:T:GS168R0.987
11:60501983:T:CF139L0.986
11:60501985:T:AF139L0.986
11:60501985:T:GF139L0.986
11:60501132:T:CF122L0.985
11:60501134:T:AF122L0.985
11:60501134:T:GF122L0.985
11:60501168:T:AW134R0.972
11:60501168:T:CW134R0.972
11:60501064:G:AG99E0.969
11:60501996:G:AG143D0.968
11:60503773:G:CD182H0.966
11:60503710:A:CS161R0.964
11:60503712:C:AS161R0.964
11:60503712:C:GS161R0.964
11:60503752:G:AG175R0.964
11:60503752:G:CG175R0.964
11:60501085:G:AG106E0.963
11:60501084:G:AG106R0.961
11:60501084:G:CG106R0.961
11:60501063:G:AG99R0.959
11:60501063:G:CG99R0.959
11:60501159:T:GY131D0.959
11:60503724:C:AN165K0.958
11:60503724:C:GN165K0.958
11:60503753:G:AG175E0.954
11:60503774:A:CD182A0.953
11:60501172:G:AG135D0.947

dbSNP variants (sampled 300 via entrez): RS1000079688 (11:60492036 G>A,T), RS1000278311 (11:60500402 A>G), RS1000505605 (11:60506498 T>C), RS1000600994 (11:60501683 TA>T,TAA), RS1000811143 (11:60491128 C>T), RS1000885946 (11:60507025 C>G), RS1000913051 (11:60495423 C>T), RS1001097774 (11:60491238 C>A,G,T), RS1001499399 (11:60501607 G>A), RS1001500376 (11:60499911 T>G), RS1001614037 (11:60501813 A>G), RS1001802983 (11:60500755 T>C), RS1001812810 (11:60491064 C>A,T), RS1002015341 (11:60496156 A>G), RS1002057714 (11:60495300 C>T)

Disease associations

OMIM: gene MIM:606550 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST004721_17Congenital heart disease (maternal effect)4.000000e-07
GCST009205_11Supramarginal gyrus volume9.000000e-06
GCST90002388_537Lymphocyte count2.000000e-16

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004587lymphocyte count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

4 total (human), top 4 by PubMed support.

ChemicalActions (top 5)PubMed papers
(+)-JQ1 compounddecreases expression1
Benzo(a)pyreneaffects methylation, increases methylation1
Cadmiumincreases expression1
Rotenonedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.